Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Obstetrics/Gynecology

RSS  

Articles

  • New microbicides enter trials in United States

    Two potential candidates in the microbicide research pipeline are set to be examined in clinical trials this fall, with research to focus on the safety and acceptability in healthy women and women infected with HIV.
  • Give teens more info to bridge information gap

    Your next patient is a 17-year-old female who is interested in contraception. While she says she knows about the contraceptive patch and the vaginal ring, when you ask her about their effectiveness in preventing sexually transmitted diseases (STDs), she gives you a puzzled look.
  • Goiter: A Review of Pathophysiology and Management

    Goiter literally means the enlargement of the thyroid gland, independent of its cause. Historically, this terminology specifically was reserved for a visibly enlarged thyroid gland. During the past few decades of modern medical practice, the term has come to include both visible as well as palpable thyroid enlargement. This article will review the pathophysiologic processes leading to goiter formation and will provide a logical approach to the diagnosis and management of different entities, the end result of which is an enlarged thyroid gland.
  • Full March 2004 Issue in PDF

  • Lower-dose injectable contraceptive moves through research pipeline

    As you check the chart of your next patient, you note she is scheduled for her quarterly injection of depot medroxyprogesterone acetate (DMPA, Depo-Provera; Pfizer, New York City). While she is on time for this shot, she was late for two such appointments in the previous year. What if there was a contraceptive injection that your patients could be instructed to use in self-injection?
  • FDA panel gives nod to adding folic acid to OC

    A pill designed to prevent unintended pregnancy and birth defects is moving closer to commercial reality following a Food and Drug Administration (FDA) advisory committees unanimous vote to back such a combination product.
  • Spray-on birth control: New application eyed

    Women now rely on contraception in such new forms as a transdermal patch and a vaginal ring. In fact, about 75% of readers participating in the 2003 Contraceptive Technology Update Contraception Survey say their facilities are offering these birth control options. What if women could get reliable birth control from a spray-on application to the skin?
  • Ask the Experts: Answers to questions on IUS use, OC interactions

    Can women who are breast-feeding use a levonorgestrel intrauterine system? What is the impact of fluconazole (Diflucan, Pfizer; New York City), an oral medication used to treat vaginal yeast infections, on oral contraceptive (OC) efficacy?
  • Full March 2004 Issue in PDF

  • Allergies and Allergy Therapy — Part II

    This monograph provides an overview of allergic disorders and reviews the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, the discussion has been limited to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved is reviewed, particularly the relationship between allergic rhinitis and asthma.